when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

6,918 products tracked · 1,831 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health131

pre_registration
fuzuloparib
fuzuloparib [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Jiangsu Hengrui Pharmaceuticals Co Ltd1 cat
Phase 2
navlimetostat
navlimetostat
Non-Small Cell Lung Cancer Bristol-Myers Squibb Co1 cat
Marketed
olaparib
Lynparza (olaparib)
Epithelial Ovarian Cancer AstraZeneca Pharmaceuticals LP1 cat
Phase 3

page 2 of 62

raludotatug deruxtecan

raludotatug deruxtecan

Adenocarcinoma Of The Gastroesophageal Junction

Daiichi Sankyo Co Ltd

1 cat

Phase 2

samuraciclib [INN]

Breast Cancer Carrick Therapeutics Ltd1 cat

Phase 3

Small-Cell Lung Cancer Shanghai Henlius Biotech Inc1 cat

Phase 2

soficabtagene geleucel

soficabtagene geleucel [INN]

T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphobla… Wugen Inc1 cat

Phase 3

Peripheral T-Cell Lymphomas (PTCL)$CRVS Corvus Pharmaceuticals, Inc.1 cat

Phase 2

Loqtorzi (toripalimab-tpzi)

Esophageal Squamous Cell Carcinoma (ESCC)$CHRS Coherus Oncology, Inc.1 cat

Phase 3

Imjudo (tremelimumab-actl)

Small-Cell Lung Cancer$AZN ASTRAZENECA PLC1 cat

Phase 2

ubidecarenone [INN]

Metastatic Adenocarcinoma of The Pancreas BPGbio Inc1 cat

Marketed

Zoladex (goserelin)

Metrorrhagia (Abnormal Uterine Bleeding) TerSera Therapeutics LLC76 cat

Marketed

(daratumumab + hyaluronidase (human recombinant))

Darzalex Faspro ((daratumumab + hyaluronidase (human recombinant)-fihj))

Multiple Myeloma (Kahler Disease) Janssen Biotech Inc16 cat

Marketed

Zynyz (retifanlimab-dlwr)

Squamous Non-Small Cell Lung Cancer$INCY INCYTE CORP6 cat

pre_registration

Imfinzi (durvalumab)

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$AZN ASTRAZENECA PLC2 cat

Marketed

Jelmyto (mitomycin)

Transitional Cell Carcinoma (Urothelial Cell Carcinoma)$URGN UroGen Pharma Ltd.1 cat

Marketed

Efudex (fluorouracil)

Basal Cell Carcinoma (Basal Cell Epithelioma) Extrovis AG42 cat

Phase 1

Metastatic Pancreatic Cancer Rise Biopharmaceutical Ltd1 cat

Marketed

Elrexfio (elranatamab-bcmm)

Refractory Multiple Myeloma$PFE PFIZER INC8 cat

Phase 1

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Molecular Targeting Technologies Inc1 cat

Phase 3

berubicin hydrochloride

berubicin hydrochloride

Recurrent Glioblastoma Multiforme (GBM)$CNSP CNS Pharmaceuticals, Inc.1 cat

Marketed

Myleran (busulfan)

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Woodward Pharma Services LLC1 cat

Marketed

Prolia (denosumab)

Glucocorticoid-Induced Osteoporosis$AMGN AMGEN INC1 cat

Marketed

Fruzaqla (fruquintinib)

Metastatic Colorectal Cancer Takeda Pharmaceuticals USA Inc1 cat

pre_registration

sacituzumab govitecan

Trodelvy (sacituzumab govitecan)

Triple-Negative Breast Cancer (TNBC)$GILD GILEAD SCIENCES, INC.1 cat

pre_registration

apatinib mesylate

CAM-RIVO (apatinib mesylate)

Hepatocellular Carcinoma Elevar Therapeutics Inc1 cat

pre_registration

iberdomide hydrochloride

iberdomide hydrochloride

Refractory Multiple Myeloma Bristol-Myers Squibb Co1 cat

Marketed

Brukinsa (zanubrutinib)

Membranous Glomerulonephritis$ONC BeOne Medicines Ltd.1 cat

Phase 3

Squamous Non-Small Cell Lung Cancer Shanghai Henlius Biotech Inc1 cat

Phase 2

Jemperli (dostarlimab-gxly)

Rectal Cancer$GSK GSK plc1 cat